18.10.2017 • NewsElaine Burridgethomas swanManufacturing

Thomas Swan Buys US Manufacturing Plant

(c) twitter.com/ThomasSwanChem
(c) twitter.com/ThomasSwanChem

UK specialty chemicals company Thomas Swan has bought a manufacturing facility in Opelika, Alabama, USA, from Apollo Chemicals, part of Mount Vernon Chemicals. Financial details were not disclosed.

Commenting on the acquisition, Tom Porter, business director of Thomas Swan's Custom Manufacturing division, said: “Existing custom manufacturing customers have asked us to add US manufacturing capability, providing a strong business case for this acquisition. We will shortly commence the process of fitting it out to allow significant room for sales growth, with the site capable of large future expansions in addition to the current plans.”

County Durham-based Swan will give the facility a major overhaul and upgrade, turning it into a flexible plant for the custom manufacture of specialty chemicals. The design will include significant glass-lined reactor capacity, something that Thomas Swan's managing director, Harry Swan, said is rare in the US, especially at the mid-scale range the company offers.

The plant will provide glass-lined, fully acid-resistant production and distillation capabilities up to 10m3 for performing a wide range of chemistries including complex polymerization under inert conditions, as well as stainless steel reactor and distillation capabilities up to 8m3 for performing high pH chemistries.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.